GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (OTCPK:SPHDF) » Definitions » Days Payable

Santhera Pharmaceuticals Holding AG (Santhera Pharmaceuticals Holding AG) Days Payable : 591.17 (As of Jun. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG Days Payable?

Santhera Pharmaceuticals Holding AG's average Accounts Payable for the six months ended in Jun. 2023 was $6.94 Mil. Santhera Pharmaceuticals Holding AG's Cost of Goods Sold for the six months ended in Jun. 2023 was $2.14 Mil. Hence, Santhera Pharmaceuticals Holding AG's Days Payable for the six months ended in Jun. 2023 was 591.17.

The historical rank and industry rank for Santhera Pharmaceuticals Holding AG's Days Payable or its related term are showing as below:

SPHDF' s Days Payable Range Over the Past 10 Years
Min: 186.07   Med: 370.49   Max: 2064.36
Current: 583.9

During the past 13 years, Santhera Pharmaceuticals Holding AG's highest Days Payable was 2064.36. The lowest was 186.07. And the median was 370.49.

SPHDF's Days Payable is ranked better than
78.04% of 715 companies
in the Biotechnology industry
Industry Median: 148.78 vs SPHDF: 583.90

Santhera Pharmaceuticals Holding AG's Days Payable increased from Jun. 2022 (360.52) to Jun. 2023 (591.17). It may suggest that Santhera Pharmaceuticals Holding AG delayed paying its suppliers.


Santhera Pharmaceuticals Holding AG Days Payable Historical Data

The historical data trend for Santhera Pharmaceuticals Holding AG's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santhera Pharmaceuticals Holding AG Days Payable Chart

Santhera Pharmaceuticals Holding AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 419.01 467.39 174.62 307.89 321.84

Santhera Pharmaceuticals Holding AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 312.34 290.21 360.52 455.46 591.17

Competitive Comparison of Santhera Pharmaceuticals Holding AG's Days Payable

For the Biotechnology subindustry, Santhera Pharmaceuticals Holding AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santhera Pharmaceuticals Holding AG's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Santhera Pharmaceuticals Holding AG's Days Payable distribution charts can be found below:

* The bar in red indicates where Santhera Pharmaceuticals Holding AG's Days Payable falls into.



Santhera Pharmaceuticals Holding AG Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Santhera Pharmaceuticals Holding AG's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

Days Payable (A: Dec. 2022 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2021 ) + Accounts Payable (A: Dec. 2022 )) / count ) / Cost of Goods Sold (A: Dec. 2022 )*Days in Period
=( (2.619 + 4.181) / 2 ) / 3.856*365
=3.4 / 3.856*365
=321.84

Santhera Pharmaceuticals Holding AG's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

Days Payable (Q: Jun. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2022 ) + Accounts Payable (Q: Jun. 2023 )) / count ) / Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=( (4.181 + 9.696) / 2 ) / 2.142*365 / 2
=6.9385 / 2.142*365 / 2
=591.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Santhera Pharmaceuticals Holding AG Days Payable Related Terms

Thank you for viewing the detailed overview of Santhera Pharmaceuticals Holding AG's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Santhera Pharmaceuticals Holding AG (Santhera Pharmaceuticals Holding AG) Business Description

Traded in Other Exchanges
Address
Hohenrainstrasse 24, Pratteln, CHE, 4133
Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives most of its revenue from the European Union.